Dow Up 1.30% Nasdaq Up 0.37%

Alkermes plc (ALKS)

-NasdaqGS
51.29 Up 1.68(3.39%) Oct 30, 4:00PM EDT
|After Hours : 51.30 Up 0.01 (0.01%) Oct 30, 4:37PM EDT
Prev Close:49.61
Open:49.40
Bid:40.63 x 1000
Ask:54.87 x 200
1y Target Est:50.92
Beta:1.71
Next Earnings Date:N/A
Day's Range:48.15 - 51.44
52wk Range:34.28 - 54.25
Volume:1,077,650
Avg Vol (3m):899,342
Market Cap:7.48B
P/E (ttm):N/A
EPS (ttm):-0.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 3.39%7.48B
ABTUp 1.75%65.40B
LLYUp 2.00%71.77B
GSKUp 0.13%108.52B

Key Statistics

Forward P/E (1 yr):170.97
P/S (ttm):12.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.27
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):8.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback